Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta in Adult ADHD
NCT00246220Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD) (4 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Conners' Adult ADHD Rating Scale Total Score at 5 weeks. Started Mar 2005; status: completed.
02
Drugs
methylphenidate-OROS
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00246220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246220.